CD38 and acute myeloid leukemia: Later, it was found that the residual immune system of NOD/SCID mice can destroy CD38+ AML cells and that after blocking the residual immune system, also CD38+ AML LSC fractions can produce leukemic engraftment in the BM of NOD/SCID mice.20